CCDC91

Chr 12

coiled-coil domain containing 91

Also known as: HSD8, p56

The protein regulates membrane traffic through the trans-Golgi network and functions in cooperation with GGA proteins to sort hydrolases to lysosomes. Mutations cause autosomal recessive intellectual disability with seizures and spasticity. This gene is highly constrained against loss-of-function variants, indicating intolerance to protein-disrupting mutations.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
5
Pubs (1 yr)
33
P/LP submissions
0%
P/LP missense
0.81
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCCDC91
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
33 unique Pathogenic / Likely Pathogenic· 52 VUS of 98 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.81LOEUF
pLI 0.000
Z-score 2.30
OE 0.51 (0.330.81)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.43Z-score
OE missense 0.92 (0.811.03)
194 obs / 211.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.51 (0.330.81)
00.351.4
Missense OE0.92 (0.811.03)
00.61.4
Synonymous OE1.13
01.21.6
LoF obs/exp: 13 / 25.5Missense obs/exp: 194 / 211.6Syn Z: -0.88
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedCCDC91-related palmoplantar keratoderma, punctate typeOTHERAD
DN
0.74top 25%
GOF
0.6442th %ile
LOF
0.2678th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

98 submitted variants in ClinVar

Classification Summary

Pathogenic30
Likely Pathogenic3
VUS52
Likely Benign3
Benign2
30
Pathogenic
3
Likely Pathogenic
52
VUS
3
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
30
0
30
Likely Pathogenic
0
0
3
0
3
VUS
0
51
1
0
52
Likely Benign
0
3
0
0
3
Benign
0
2
0
0
2
Total05634090

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CCDC91 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC